Cargando…

Recommendations for Advancing the Diagnosis and Management of Hereditary Breast and Ovarian Cancer in Brazil

PURPOSE: The objective of this review was to address the barriers limiting access to genetic cancer risk assessment and genetic testing for individuals with suspected hereditary breast and ovarian cancer (HBOC) through a review of the diagnosis and management steps of HBOC. METHODS: A selected panel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Achatz, Maria Isabel, Caleffi, Maira, Guindalini, Rodrigo, Marques, Renato Moretti, Nogueira-Rodrigues, Angelica, Ashton-Prolla, Patricia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Clinical Oncology 2020
Materias:	Special Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113069/ https://www.ncbi.nlm.nih.gov/pubmed/32155091 http://dx.doi.org/10.1200/JGO.19.00170

Ejemplares similares

The Brazilian Hereditary Cancer Network: historical aspects and challenges for clinical cancer genetics in the public health care system in Brazil
por: Ashton-Prolla, Patricia, et al.
Publicado: (2016)

Screening for germline BRCA1, BRCA2, TP53 and CHEK2 mutations in families at-risk for hereditary breast cancer identified in a population-based study from Southern Brazil
por: Palmero, Edenir Inêz, et al.
Publicado: (2016)

A DNA repair variant in POLQ (c.-1060A > G) is associated to hereditary breast cancer patients: a case–control study
por: Brandalize, Ana Paula Carneiro, et al.
Publicado: (2014)

Population prevalence of hereditary breast cancer phenotypes and implementation of a genetic cancer risk assessment program in southern Brazil
por: Palmero, Edenir I., et al.
Publicado: (2009)

The Development of the Study of Hereditary Cancer in South America
por: Rossi, Benedito Mauro, et al.
Publicado: (2016)

Hereditary cancer syndromes: opportunities and challenges
por: Ashton-Prolla, Patricia
Publicado: (2013)

BRCA1 and BRCA2 rearrangements in Brazilian individuals with Hereditary Breast and Ovarian Cancer Syndrome
por: Ewald, Ingrid Petroni, et al.
Publicado: (2016)

Prevalence of the BRCA1 founder mutation c.5266dupin Brazilian individuals at-risk for the hereditary breast and ovarian cancer syndrome
por: Ewald, Ingrid P, et al.
Publicado: (2011)

Prevalence of the TP53 p.R337H Mutation in Breast Cancer Patients in Brazil
por: Giacomazzi, Juliana, et al.
Publicado: (2014)

Challenge of Incorporating New Drugs for Breast Cancer in Brazil: A Proposed Framework for Improving Access to Innovative Therapies
por: Barrios, Carlos, et al.
Publicado: (2021)

Prevalence and impact of founder mutations in hereditary breast cancer in Latin America
por: Ashton-Prolla, Patricia, et al.
Publicado: (2014)

Diagnosis and treatment of systemic mastocytosis in Brazil: Recommendations of a multidisciplinary expert panel
por: Velloso, Elvira D. Rodrigues Pereira, et al.
Publicado: (2022)

Development and validation of a simple questionnaire for the identification of hereditary breast cancer in primary care
por: Ashton-Prolla, Patricia, et al.
Publicado: (2009)

Performance of the Gail and Tyrer-Cuzick breast cancer risk assessment models in women screened in a primary care setting with the FHS-7 questionnaire
por: Vianna, Fernanda Sales Luiz, et al.
Publicado: (2019)

Haplotypic characterization of BRCA1 c.5266dupC, the prevailing mutation in Brazilian hereditary breast/ovarian cancer
por: Gomes, Renan, et al.
Publicado: (2020)

Knowledge about breast cancer and hereditary breast cancer among nurses in a public hospital
por: Prolla, Carmen Maria Dornelles, et al.
Publicado: (2015)

BRCA1 and BRCA2 mutational profile and prevalence in hereditary breast and ovarian cancer (HBOC) probands from Southern Brazil: Are international testing criteria appropriate for this specific population?
por: Alemar, Bárbara, et al.
Publicado: (2017)

Germline Pathogenic Variant Prevalence Among Latin American and US Hispanic Individuals Undergoing Testing for Hereditary Breast and Ovarian Cancer: A Cross-Sectional Study
por: Ossa Gomez, Carlos Andrés, et al.
Publicado: (2022)

A model to optimize public health care and downstage breast cancer in limited-resource populations in southern Brazil. (Porto Alegre Breast Health Intervention Cohort)
por: Caleffi, Maira, et al.
Publicado: (2009)

Correction: BRCA1 and BRCA2 mutational profile and prevalence in hereditary breast and ovarian cancer (HBOC) probands from Southern Brazil: Are international testing criteria appropriate for this specific population?
por: Alemar, Bárbara, et al.
Publicado: (2018)

Comparison of multiple genotyping methods for the identification of the cancer predisposing founder mutation p.R337H inTP53
por: Fitarelli-Kiehl, Mariana, et al.
Publicado: (2016)

Prevalence of the Brazilian TP53 Founder c.1010G>A (p.Arg337His) in Lung Adenocarcinoma: Is Genotyping Warranted in All Brazilian Patients?
por: Vieira, Igor Araujo, et al.
Publicado: (2021)

Early-onset breast cancer patients in the South and Southeast of Brazil should be tested for the TP53 p.R337H mutation
por: Andrade, Kelvin C., et al.
Publicado: (2016)

Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis
por: Yoshida, Reiko
Publicado: (2020)

Breast cancer survival in Brazil: How much health care access impact on cancer outcomes?
por: Caleffi, Maira, et al.
Publicado: (2020)

Human sporotrichosis: recommendations from the Brazilian Society of Dermatology for the clinical, diagnostic and therapeutic management()
por: Orofino-Costa, Rosane, et al.
Publicado: (2022)

Ancestry of the Brazilian TP53 c.1010G>A (p.Arg337His, R337H) Founder Mutation: Clues from Haplotyping of Short Tandem Repeats on Chromosome 17p
por: Paskulin, Diego Davila, et al.
Publicado: (2015)

Integrated control of neglected tropical diseases in Brazil: document review of a national campaign in light of WHO recommendations
por: Soares, Rosa Castália Ribeiro, et al.
Publicado: (2023)

Pitfalls of delaying the diagnosis of hereditary haemorrhagic telangiectasia
por: Major, Tamás, et al.
Publicado: (2019)

Germline variants in DNA repair genes associated with hereditary breast and ovarian cancer syndrome: analysis of a 21 gene panel in the Brazilian population
por: da Costa e Silva Carvalho, Simone, et al.
Publicado: (2020)

Delivering Cancer Care During the COVID-19 Pandemic: Recommendations and Lessons Learned From ASCO Global Webinars
por: Jazieh, Abdul Rahman, et al.
Publicado: (2020)

Quality of Life of the Plastic Surgeon in the Midwest of Brazil
por: de Arruda, Fabiano Calixto, et al.
Publicado: (2018)

Cancer-related worry and risk perception in Brazilian individuals seeking genetic counseling for hereditary breast cancer
por: Palmero, Edenir Inêz, et al.
Publicado: (2020)

Profile of dermatological consultations in Brazil (2018)
por: Miot, Hélio Amante, et al.
Publicado: (2018)

Germline molecular data in hereditary breast cancer in Brazil: Lessons from a large single-center analysis
por: Sandoval, Renata Lazari, et al.
Publicado: (2021)

Recommendations for the pharmacological treatment of COPD: questions and answers
por: Fernandes, Frederico Leon Arrabal, et al.
Publicado: (2017)

Hereditary breast and ovarian cancer: assessment of point mutations and copy number variations in Brazilian patients
por: Silva, Felipe C, et al.
Publicado: (2014)

Association of adipokines and adhesion molecules with indicators of obesity in women undergoing mammography screening
por: Isoppo de Souza, Caroline, et al.
Publicado: (2012)

Skin pigmentation polymorphisms associated with increased risk of melanoma in a case-control sample from southern Brazil
por: Reis, Larissa B., et al.
Publicado: (2020)

Retinoblastoma in a pediatric oncology reference center in Southern Brazil
por: Selistre, Simone G. A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_3atdlqcj2n3frgv531eele6566